New South Wales to Get Pilot RNA Manufacturing and Research Facility

New South Wales to Get Pilot RNA Manufacturing and Research Facility
A pharmacist prepares the Pfizer-BioNTech COVID-19 mRNA vaccine at a pharmacy prototype clinic in Halifax on March 9, 2021. Andrew Vaughan/The Canadian Press
|Updated:

NSW is committing $96 million to establish a facility to develop and manufacture the emerging medical technology of mRNA and RNA drugs used to develop vaccines like those created for COVID-19 by Pfizer and Moderna.

Premier Dominic Perrottet said the facility—at a site yet to be determined—would position the state as a world leader in biotechnology, noting it would be a game-changer in the field of medical research.